Price target
359.700.00 0.00%
The 21 analysts offering 1 year price forecasts for GE9 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 27 analysts giving stock ratings to GE9 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GE9 EPS for the last quarter is 2.70 EUR despite the estimation of 1.73 EUR. In the next quarter EPS is expected to reach 2.78 EUR. Track more of GENMAB AS DK 1 financials and stay on top of what is up with the company.
In the next quarter GENMAB AS DK 1 revenue is expected to reach 667.28 M EUR. Check out GENMAB AS DK 1 revenue and earnings and make informed decisions.
According to analysts, GE9 price target is 359.70 EUR with a max estimate of 463.17 EUR and a min estimate of 248.73 EUR. Check if this forecast comes true in a year, meanwhile watch GENMAB AS DK 1 stock price chart and keep track of the current situation with GE9 news and stock market news.
We've gathered opinions of 27 analysts rating GE9 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.